Savient raises $44M, restructures debt

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) said on Wednesday it restructured debt and raised about $44 million through a sale of units comprising notes and warrants. The move comes after the Delaware Court of Chancery denied a request from creditor Tang Capital Partners for a temporary restraining order seeking to prevent Savient from conducting a financing. ...